Zoetis (ZTS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · United States · ISIN US98978V1035

Price
75.29 USD
Market cap
31.11 bn USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
2.78 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Zoetis financials

Fiscal year2025
Revenue9.47 bn USD
Gross profit6.80 bn USD
EBIT3.58 bn USD
Net income2.67 bn USD
Diluted EPS – continuing operations6.02 USD

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.

Zoetis stock (ZTS): P/E, revenue, dividend | finmetric